Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of oxaliplatin plus irinotecan in treating patients with previously treated metastatic gastrointestinal cancer that has not responded to previous treatment.

DISEASE(S): Gastrointestinal Neoplasms,Carcinoid Tumor,Colorectal Cancer,Liver Cancer,Small Intestine Cancer,Pancreatic Cancer,Gallbladder Cancer,Extrahepatic Bile Duct Cancer,Liver Neoplasms,Anus Neoplasms,Gastrointestinal Carcinoid Tumor,Malignant Carcinoid Syndrome,Esophageal Neoplasms,Gastric Cancer,Gallbladder Neoplasms,Bile Duct Neoplasms,Esophageal Cancer,Anal Cancer,Pancreatic Neoplasms,Stomach Neoplasms,Intestinal Neoplasms,Cholangiocarcinoma

PROVIDER: 2002957 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR